Rappler's latest stories on AstraZeneca
'Our present assumption is that we will have the data by the end of the summer, by August, so in September we should know whether we have an effective vaccine or not,' says AstraZeneca chief executive Pascal Soriot
'We are now initiating studies to evaluate how well the vaccine induces immune responses in older adults, and to test whether it can provide protection in the wider population,' says the Oxford Vaccine Group
The company says it is 'engaging with international organizations,' including the World Health Organization, 'for the fair allocation and distribution of the vaccine around the world'
The strategic collaboration is expected to further increase the number of treatment options available to patients British company AstraZeneca and its US peer Merck say in a statement
About 7 out of 10 Filipino adults diagnosed with type 2 diabetes are overweight and obese